Navigation Links
LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
Date:10/21/2008

LegalView reintroduced its Avandia practice area to include updated information for victims of the drug's side effects. Avandia has been linked to the development of early on-set osteoporosis and heart failure among patients.

Denver (PRWEB) October 21, 2008 -- LegalView.com, the most comprehensive legal resource available on the Web, recently re-launched its Avandia information portal to provide the most up-to-date news on potential Avandia side effects recently associated with patients taking the drug.

Those affected by the drug's side effects are advised to locate a pharmaceutical attorney as it may be necessary to develop an Avandia lawsuit to retrieve monetary compensation for the damages caused by the prescription drug.

Avandia (risiglitazone maleate) is a type 2 diabetes treatment from GlaxoSmithKline and was released in mid-1999. The drug was part of a new group of drugs that work to use the body's natural insulin to regulate blood glucose levels. In May 2007, the U.S. Food and Drug Administration (FDA) issued a health advisory for the drug, notating its potential risks for causing heart attacks and heart-related deaths among Avandia patients.

Additionally, in June 2007 the New England Journal of Medicine reported the severe dangers of heart failure among Avandia patients and found a 43 percent increase of heart attack among drug patients. Another study conducted by a group of Swiss researchers also found that those consuming Avandia were more likely to develop early on-set osteoporosis and bone fractures/bone breaks while taking the drug. Because of the Avandia risks of osteoporosis and heart failure it is important for Avandia patients to consult their physician if they feel that they may be at risk for developing any of the Avandia risks.

Type 2 diabetes is a serious and potentially fatal condition that is difficult to treat. According to the American Diabetes Association (ADA), several million Americans currently suffer from diabetes. Individuals who have the condition are at an increased risk for developing complications such as heart disease, kidney damage, blindness and nerve damage. Because of this potential for complications it becomes increasingly important and dangerous when prescription drugs, such as Avandia, add to the risk of causing diabetes complications. Individuals who have been given a prescription for Avandia should consult a physician immediately if they feel they may develop any of the drug's side effects. Additionally, contacting an Avandia law firm may be important to protect patients. Consulting a knowledgeable Avandia lawyer may provide insight into developing an Avandia class action lawsuit to retrieve monetary compensation for the damages caused by the drug.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

###

Read the full story at http://www.prweb.com/releases/2008/10/prweb1500804.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
5. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
6. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
7. LegalView Re-launching Truck Accident Injury Information Portal with Updated News and Information on the Costly and Dangerous Accidents
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
10. LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance
11. MedQuist Re-launches New, Improved Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... The new knee compression sleeves ... to buy neoprene knee sleeves for lifting and any sport that requires ... on two main aspects to provide a higher quality knee sleeve performance. Firstly it ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... today that they have teamed up with The American College of Surgeons (ACS) ... ACS’s Committee on Trauma, the “Bleeding Control Basic” course is a pilot program ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 04, 2016 , ... "Pro3rd Displace ... animation styles with unique displacement design elements," said Christina Austin - CEO of ... Choose from a variety of design styles that include both left aligned and ...
(Date:12/2/2016)... ... 2016 , ... Halfway through its partnership with First 5 LA, Western University ... than 15,900 children 5 years old and younger and treatment services to more than ... of five years to Western University of Health Sciences, UCLA and USC, beginning March ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 PharmaBoardroom today releases ... . ... This report offers companies, investors, policymakers, and stakeholders crucial insight ... of Europe , home to some of the world,s ... pharmaceutical companies in Novartis and Roche, and with a number one ranking ...
(Date:12/5/2016)... VIENNA and TAIPEI, Taiwan , ... 12 months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea ... demonstrated a significantly better safety and tolerability profile of ropeginterferon ... data from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV ... PharmaEssentia intends to present this data to the ...
(Date:12/4/2016)... ORLEANS , Dec. 2, 2016  Former Attorney General ... Jr., Esq. , a partner at the law firm of ... commenced an investigation into Lannett Company, Inc. (NYSE: ... Bloomberg published an article titled "U.S. Charges in Generic-Drug ... "antitrust investigation by the Justice Department, begun about two years ...
Breaking Medicine Technology: